NCT04480008
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Enrolling by invitation
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: Patient must have had prior disease progression on all standard therapies for their tumor
Exclusions: Patients with untreated or uncontrolled central nervous system (CNS) metastases
https://ClinicalTrials.gov/show/NCT04480008